Humira is an injectable drug used in the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Crohn's disease. This drug is available as an injection solution containing adalimumab 40 milligrams in 0.8 milliliter or adalimumab 40 milligrams in 0.8 milliliter.
You should read the product information leaflet before using this medication. If you have any questions, ask your doctor or pharmacist.
This medication should be injected under the skin weekly or every other week as directed by your doctor. Do not inject on broken or damaged skin. Your dosage is based on your medical condition and the way you will respond to treatment.
If you miss a dose, use it as soon as you remember. Continue to use it as prescribed by your doctor or as stated on the package label.
Humira may interact with medications such as:
- Live vaccines
- Other TNF-blockers such as:
- or Infliximab
- Other arthritis drugs such as:
- or Anakinra
- Drugs that suppress the immune system such as:
There are no side effects known aside from a possible allergic reaction in people who have previous or unknown hypersensitivity to the drug.
Watch out for signs of allergic reactions such as:
Before taking this medication, tell your doctor or pharmacist if you have the following:
- Allergy to Adalimumab
- An active infection
- TB infection
- Fungal infections (histoplasmosis)
- Congestive heart failure
- Recurrent infections
- Hepatitis B infection
- Decreased bone marrow function
- Brain, spinal cord or nerve disorders
- History of cancer (lymphoma)
- Scheduled surgery
- Pregnancy or lactation